Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.05 USD | -0.97% | -8.47% | -47.41% |
Financials (USD)
Sales 2024 * | 65.38M | Sales 2025 * | 6.25M | Capitalization | 20.52M |
---|---|---|---|---|---|
Net income 2024 * | 24M | Net income 2025 * | -41M | EV / Sales 2024 * | 0.31 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.28 x |
P/E ratio 2024 * |
0.94
x | P/E ratio 2025 * |
-0.53
x | Employees | 46 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.46% |
Latest transcript on MEI Pharma, Inc.
1 day | -0.97% | ||
1 week | -8.47% | ||
Current month | -23.75% | ||
1 month | -21.47% | ||
3 months | -33.98% | ||
6 months | -55.28% | ||
Current year | -47.41% |
Managers | Title | Age | Since |
---|---|---|---|
David Urso
CEO | Chief Executive Officer | 60 | 14-03-06 |
Justin File
DFI | Director of Finance/CFO | 53 | 23-06-11 |
Caroline Ruiz
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 74 | 18-02-25 |
Thomas Reynolds
BRD | Director/Board Member | 65 | 13-02-10 |
Charles Baltic
CHM | Chairman | 63 | 11-10-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 3.05 | -0.97% | 1 534 |
24-04-29 | 3.08 | +0.98% | 9,152 |
24-04-26 | 3.05 | -1.61% | 8,066 |
24-04-25 | 3.1 | -4.91% | 16,736 |
24-04-24 | 3.26 | -2.17% | 7,394 |
Delayed Quote Nasdaq, April 30, 2024 at 01:15 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-47.41% | 20.52M | |
+0.63% | 42.86B | |
+12.13% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+5.87% | 25.15B | |
-23.81% | 18.63B | |
+28.16% | 12.37B | |
-3.49% | 11.92B | |
+7.00% | 11.21B |
- Stock Market
- Equities
- MEIP Stock